Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy
Autor
Brozos-Vázquez, Elena María
Díaz-Peña, Roberto
García-González, Jorge
Leon Mateos, Luis
Mondelo-Macía, Patricia
Peña-Chilet, María
López-López, Rafael
Resumen
Immunotherapy has been one of the great advances in the recent years for the treatment of advanced tumors, with nonsmall-cell lung cancer (NSCLC) being one of the cancers that has benefited most from this approach. Currently, the only validated companion diagnostic test for first-line immunotherapy in metastatic NSCLC patients is testing for programmed death ligand 1 (PD-L1) expression in tumor tissues. However, not all patients experience an effective response with the established selection criteria and immune checkpoint inhibitors (ICIs). Liquid biopsy offers a noninvasive opportunity to monitor disease in patients with cancer and identify those who would benefit the most from immunotherapy. This review focuses on the use of liquid biopsy in immunotherapy treatment of NSCLC patients. Circulating tumor cells (CTCs), cell-free DNA (cfDNA) and exosomes are promising tools for developing new biomarkers. We discuss the current application and future implementation of these parameters to improve therapeutic decision-making and identify the patients who will benefit most from immunotherapy.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients (2024)
Mondelo-Macía, Patricia; García-González, Jorge; Abalo, Alicia; Mosquera-Presedo, Manuel; Aguín, Santiago; Mateos, María; López-López, Rafael; León-Mateos, Luis; Muinelo-Romay, Laura; Díaz-Peña, Roberto (AME Publishing Company, 2022)Background: Lack of biomarkers for treatment selection and monitoring in small cell lung cancer (SCLC) patients with the limited therapeutic options, result in poor outcomes. Therefore, new prognostic biomarkers are needed ... -
Article
Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study (2024)
Rapado-González, Óscar; Brea-Iglesias, Jenifer; Rodríguez-Casanova, Aitor; Bao-Caamano, Aida; López-Cedrún, José-Luis; Triana-Martínez, Gabriel; Díaz-Peña, Roberto; Santos, María Arminda; López-López, Rafael; Muinelo-Romay, Laura; ... (John Wiley and Sons Inc, 2023)Background: We explore the utility of TruSight Tumor 170 panel (TST170) for detecting somatic mutations in tumor and cfDNA from locoregional recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Methods: ... -
Article
Acquisition of new migratory properties by highly differentiated cd4+cd28null t lymphocytes in rheumatoid arthritis disease (2021)
Rioseras, Beatriz; Moro-García, Marco Antonio; García-Torre, Alejandra; Bueno-García, Eva; López-Martínez, Rocio; Iglesias-Escudero, María; Díaz-Peña, Roberto; Castro-Santos, Patricia; Arias-Guillén, Miguel; Alonso-Arias, R. (MDPI AG, 2021-07)Expanded CD4+CD28null T lymphocytes are found in the tissues and peripheral blood of patients with many autoimmune diseases, such as rheumatoid arthritis (RA). These highly differentiated cells present potent inflammatory ...